POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,428 | +26.8% | 24,969 | -6.2% | 0.03% | +25.9% |
| Q2 2023 | $46,850 | +1.1% | 26,619 | +77.0% | 0.03% | +12.5% |
| Q1 2023 | $46,324 | -42.8% | 15,040 | -1.5% | 0.02% | -44.2% |
| Q4 2022 | $80,934 | +37.2% | 15,270 | -2.4% | 0.04% | +38.7% |
| Q3 2022 | $59,000 | -3.3% | 15,650 | -33.0% | 0.03% | +3.3% |
| Q2 2022 | $61,000 | -49.6% | 23,370 | -12.7% | 0.03% | -33.3% |
| Q1 2022 | $121,000 | +68.1% | 26,770 | +152.1% | 0.04% | +87.5% |
| Q4 2021 | $72,000 | 0.0% | 10,620 | +2.7% | 0.02% | -7.7% |
| Q3 2021 | $72,000 | – | 10,345 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |